title: Adjustable degradation and drug release of a thermosensitive hydrogel based on a pendant cyclic ether modified poly(ε-caprolactone) and poly(ethylene glycol)co-polymer.
abstract: The convenient and precise fabrication of drug-hydrogel formulations with satisfactory degradability and a well-controlled drug release profile are crucial factors for injectable hydrogel formulations in clinical applications. Here a new injectable thermosensitive hydrogel formed from poly(ε-caprolactone) (PCL)-poly(ethylene glycol)-poly(ε-caprolactone) amphiphilicco-polymers with 1,4,8-trioxa[4.6]spiro-9-undecanone (TOSUO) moieties incorporated in the poly(ε-caprolactone) (PCL)block (PECT) was constructed to provide a route to tailor the degradation and drug release behavior. The effect of hydrophilic cyclic ether moieties on the degradation of and drug release by PECT hydrogels were evaluated in vitro and in vivo. The results indicated that a freeze-dried powder of paclitaxel-loaded PECT nanoparticles rapidly dissolved in water at ambient temperature with slightly shaking and formed a stable injectable in situ drug-hydrogel formulation at body temperature, which is convenient for clinical operations because it avoids the need for pre-quenching or long-term incubation. The paclitaxel distribution was also more quantitative and homogeneous on entrapping paclitaxel in PECT nanoparticles. Further, the small number of pendant cyclic ether groups in PCL could decrease the cystallinity and hydrophobicity and, as a result, the in vitro and in vivo retention time of PECT hydrogels and the release of entrapped paclitaxel could be tuned from a few weeks to months by varying the amount of PTOSUO in the hydrophobic block. Significantly, paclitaxel-loaded PECT nanoparticles and free paclitaxel could be simultaneously released during the in vitro paclitaxel release from PECT hydrogels. A histopathological evaluation indicated that in vivo injected PECT hydrogels produced only a modest inflammatory response. Thus pendant cyclic ether modification of PCL could be an effective way to achieve the desired degradation and drug release profiles of amphiphilicco-polymer thermosensitive hydrogels and PECT hydrogels may be suitable for local drug delivery.
authors: School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, People's Republic of China.
authors: Weiwei
authors: W
authors: Wang
authors: Liandong
authors: L
authors: Deng
authors: Shasha
authors: S
authors: Liu
authors: Xu
authors: X
authors: Li
authors: Xiumei
authors: X
authors: Zhao
authors: Renjie
authors: R
authors: Hu
authors: Jianhua
authors: J
authors: Zhang
authors: Haijie
authors: H
authors: Han
authors: Anjie
authors: A
authors: Dong
mesh_terms: D000818:Animals; D002152:Calorimetry, Differential Scanning; D004988:Ethers, Cyclic / Q000737:chemistry*; D005612:Freeze Drying; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate / Q000737:chemistry*; D008422:Materials Testing; D051379:Mice; D008970:Molecular Weight; D053758:Nanoparticles / Q000737:chemistry / Q000648:ultrastructure; D017239:Paclitaxel / Q000494:pharmacology*; D010316:Particle Size; D044367:Phase Transition / Q000187:drug effects; D011091:Polyesters / Q000737:chemistry*; D011092:Polyethylene Glycols / Q000737:chemistry*; D012995:Solubility; D012996:Solutions; D013141:Spiro Compounds / Q000737:chemistry; D013696:Temperature; D014961:X-Ray Diffraction
chemical_list: D004988:Ethers, Cyclic; D011091:Polyesters; D012996:Solutions; D013141:Spiro Compounds; C016240:polycaprolactone; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate; D011092:Polyethylene Glycols; D017239:Paclitaxel